Loading…
Workplace Overdose Reversal Kits to Save Lives Act
Legislative Progress
Introduced
September 12, 2023
Latest Action
September 12, 2023
Primary Sponsor
Bonnie Watson ColemanDemocratic(NJ)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (11)
Referred to the House Committee on Education and the Workforce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2026 · first_quarter · Health Issues
GHAI Overdose Initiative (under healthcare issue code): Legislation: FY 26 Appropriations bills Modernizing Opioid Treatment Access Act PEER Support Act H.R. 5420 - Workplace Overdose Reversal Kits to Save Lives Act S.3522 - No Red Tape For Addiction Treatment Act S. 1165/H. R. 2586, Reentry Act S. 1720/H.R. 1510, Due Process Continuity of Care Act S. 2697, Due Process Continuity of Care Act SUPPORT for Patients and Communities Reauthorization Act Issues: Medicaid prior authorization requirements Access to medications for opioid use disorder Overdose prevention Racial disparities in overdose deaths Financing (grants) for behavioral health care services and programs Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate
Client expense: $430,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Health Issues
GHAI Overdose Initiative (under healthcare issue code): Legislation: FY 26 Appropriations bills Modernizing Opioid Treatment Access Act PEER Support Act H.R. 5420 - Workplace Overdose Reversal Kits to Save Lives Act S.3522 - No Red Tape For Addiction Treatment Act S. 1165/H. R. 2586, Reentry Act S. 1720/H.R. 1510, Due Process Continuity of Care Act S. 2697, Due Process Continuity of Care Act SUPPORT for Patients and Communities Reauthorization Act Issues: Medicaid prior authorization requirements Access to medications for opioid use disorder Overdose prevention Racial disparities in overdose deaths Agencies Visited: Centers for Disease Control and Prevention US House of Representatives US Senate
Client expense: $980,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Health Issues
Asking Congress to cosponsor H.R. 2474, the Strengthening Medicare for Patients and Providers Act, which would align Medicare physician payments with other sectors of Medicare by adding a mandatory annual inflation update. To also cosponsor H.R. 6371, the Provider Reimbursement Stability Act, which would increase the budget-neutrality threshold, set limits on conversion factor variance, and allow CMS to enhance accountability and stability within the physician payment system. Support H.R. 5625, the Fentanyl Awareness for Children and Teens in Schools (FACTS) Act, which would help to address the opioid crisis by making naloxone available in school settings. Support H.R. 5420 / S. 2948, the Workplace Overdose Reversal Kits (WORK) to Save Lives Act which would require opioid overdose reversal medications to be in federal buildings and create non-mandatory guidance for private employers on how to obtain these medications; both important measures to reduce opioid overdose fatalities. Support H.R. 6161, the Supporting Access to Vital and Affordable Care for Everyone (SAVE) Act, which would make access to over-the-counter naloxone more affordable by ensuring it qualifies as a deductible medical expense.
Client expense: Not reported · Firm income: $10,000
2025 · first_quarter · Health Issues
Asking Congress to cosponsor H.R. 2474, the Strengthening Medicare for Patients and Providers Act, which would align Medicare physician payments with other sectors of Medicare by adding a mandatory annual inflation update. To also cosponsor H.R. 6371, the Provider Reimbursement Stability Act, which would increase the budget-neutrality threshold, set limits on conversion factor variance, and allow CMS to enhance accountability and stability within the physician payment system. Support H.R. 5625, the Fentanyl Awareness for Children and Teens in Schools (FACTS) Act, which would help to address the opioid crisis by making naloxone available in school settings. Support H.R. 5420 / S. 2948, the Workplace Overdose Reversal Kits (WORK) to Save Lives Act which would require opioid overdose reversal medications to be in federal buildings and create non-mandatory guidance for private employers on how to obtain these medications; both important measures to reduce opioid overdose fatalities. Support H.R. 6161, the Supporting Access to Vital and Affordable Care for Everyone (SAVE) Act, which would make access to over-the-counter naloxone more affordable by ensuring it qualifies as a deductible medical expense.
Client expense: Not reported · Firm income: $10,000
2024 · fourth_quarter · Budget/Appropriations
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240 H.R. 10445, the Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 H.R.10545 - American Relief Act, 2025
Client expense: Not reported · Firm income: $30,000
| Democratic |
| OR |
| André Carson | Democratic | IN |
| Angie Craig | Democratic | MN |
| Barbara Lee | Democratic | CA |
| Bill Pascrell, Jr. | Democratic | NJ |
| Brian K. Fitzpatrick | Republican | PA |
| Brittany Pettersen | Democratic | CO |
| David J. Trone | Democratic | MD |
| Dean Phillips | Democratic | MN |
| Dina Titus | Democratic | NV |
| Donald Norcross | Democratic | NJ |
| Doug Lamborn | Republican | CO |
| Eleanor Holmes Norton | Democratic | DC |
| Gwen Moore | Democratic | WI |
| Harold Rogers | Republican | KY |
| Jasmine Crockett | Democratic | TX |
| Jennifer L. McClellan | Democratic | VA |
| John H. Rutherford | Republican | FL |
| Jonathan L. Jackson | Democratic | IL |
| Joseph D. Morelle | Democratic | NY |
| Katie Porter | Democratic | CA |
| Marcus J. Molinaro | Republican | NY |
| Nancy Mace | Republican | SC |
| Nikki Budzinski | Democratic | IL |
| Paul Tonko | Democratic | NY |
| Raja Krishnamoorthi | Democratic | IL |
| Raúl M. Grijalva | Democratic | AZ |
| Sean Casten | Democratic | IL |
| Sheila Jackson Lee | Democratic | TX |
| Shri Thanedar | Democratic | MI |
| Teresa Leger Fernandez | Democratic | NM |
| Thomas R. Suozzi | Democratic | NY |
| Tony Cárdenas | Democratic | CA |
| Troy A. Carter | Democratic | LA |
| Wiley Nickel | Democratic | NC |
| William R. Keating | Democratic | MA |
| Yadira Caraveo | Democratic | CO |
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Disaster Planning/Emergencies
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240 H.R. 10445, the Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 H.R.10545 - American Relief Act, 2025
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Homeland Security
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240 H.R. 10445, the Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 H.R.10545 - American Relief Act, 2025
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Homeland Security
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240 CR - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 H.R. 10545, the American Relief Act, 2025
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Budget/Appropriations
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240 CR - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 H.R. 10545, the American Relief Act, 2025
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Disaster Planning/Emergencies
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240 CR - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 H.R. 10545, the American Relief Act, 2025
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240 CR - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 H.R. 10545, the American Relief Act, 2025
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
- S.2333 - Pandemic and All-Hazards Preparedness and Response Act, provisions related to health care provider workforce - S.1176 & H.R.2663 - Workplace Violence Prevention for Health Care and Social Service Workers Act - S.4928 - Beryllium Testing Fairness Act - H.R.4897 & S.2501 - Asuncion Valdivia Heat Illness and Fatality Prevention Act - H.R.5420 & S.2948 - WORK (Workplace Overdose Reversal Kits) to Save Lives Act - H.R. 766 & S.114 - Dr. Michael C. Burgess Preventive Health Savings Act - Authorization legislation to establish a program to provide federal support to graduate medical education programs in occupational and environmental medicine. - Medicare GME system reforms to accommodate support for additional medical specialty residency funding support. - Support of Congressional oversight on issues related to occupational respirable crystalline silica exposures. - Support of Congressional oversight on issues related to occupational lead exposures. - Support of Congressional oversight on issues related to on-site workplace clinic illness and injury management.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Occupational Safety & Health Administration (OSHA), SENATE
2024 · fourth_quarter · Health Issues
Asking Congress to cosponsor H.R. 2474, the Strengthening Medicare for Patients and Providers Act, which would align Medicare physician payments with other sectors of Medicare by adding a mandatory annual inflation update. To also cosponsor H.R. 6371, the Provider Reimbursement Stability Act, which would increase the budget-neutrality threshold, set limits on conversion factor variance, and allow CMS to enhance accountability and stability within the physician payment system. Support H.R. 5625, the Fentanyl Awareness for Children and Teens in Schools (FACTS) Act, which would help to address the opioid crisis by making naloxone available in school settings. Support H.R. 5420 / S. 2948, the Workplace Overdose Reversal Kits (WORK) to Save Lives Act which would require opioid overdose reversal medications to be in federal buildings and create non-mandatory guidance for private employers on how to obtain these medications; both important measures to reduce opioid overdose fatalities. Support H.R. 6161, the Supporting Access to Vital and Affordable Care for Everyone (SAVE) Act, which would make access to over-the-counter naloxone more affordable by ensuring it qualifies as a deductible medical expense.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2024 · fourth_quarter · Consumer Issues/Safety/Products
Susan Harwood Training Grants; Occupational Safety and Health Administration heat standard; Marijuana use and protections for workplace safety and health; Mental Health; Substance Abuse and Awareness; H.R.4897/S.2501 - Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act of 2023; Worker Walkaround Representative Designation Process; H.R. 5420, Workplace Overdose Reversal Kits (WORK) to Save Lives Act; H.J.Res.147 - Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Occupational Safety and Health Administration relating to "Worker Walkaround Representative Designation Process"; S.4260 - Warehouse Worker Protection Act
Client expense: $234,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE
2024 · fourth_quarter · Health Issues
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone FAA reauthorization - increasing access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240 CR - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 H.R. 10545, the American Relief Act, 2025
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
H.R.5420/S.2948 - WORK to Save Lives Act - growing co-sponsorship support for bill effort which mandates naloxone be available in Public buildings and have OSHA create guidance for private employers stocking it Issues related to NIOSH creating workplace-centered mental health programs
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
H.R.5420/S.2948 - WORK to Save Lives Act - growing co-sponsorship support for bill effort which mandates naloxone be available in Public buildings and have OSHA create guidance for private employers stocking it Issues related to NIOSH creating workplace-centered mental health programs
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Budget/Appropriations
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Disaster Planning/Emergencies
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Homeland Security
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Homeland Security
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Disaster Planning/Emergencies
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Budget/Appropriations
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
Asking Congress to cosponsor H.R. 2474, the Strengthening Medicare for Patients and Providers Act, which would align Medicare physician payments with other sectors of Medicare by adding a mandatory annual inflation update. To also cosponsor H.R. 6371, the Provider Reimbursement Stability Act, which would increase the budget-neutrality threshold, set limits on conversion factor variance, and allow CMS to enhance accountability and stability within the physician payment system. Support H.R. 5625, the Fentanyl Awareness for Children and Teens in Schools (FACTS) Act, which would help to address the opioid crisis by making naloxone available in school settings. Support H.R. 5420 / S. 2948, the Workplace Overdose Reversal Kits (WORK) to Save Lives Act which would require opioid overdose reversal medications to be in federal buildings and create non-mandatory guidance for private employers on how to obtain these medications; both important measures to reduce opioid overdose fatalities. Support H.R. 6161, the Supporting Access to Vital and Affordable Care for Everyone (SAVE) Act, which would make access to over-the-counter naloxone more affordable by ensuring it qualifies as a deductible medical expense.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2024 · third_quarter · Consumer Issues/Safety/Products
Susan Harwood Training Grants; Occupational Safety and Health Administration heat standard; Marijuana use and protections for workplace safety and health; Mental Health; Substance Abuse and Awareness; H.R.4897/S.2501 - Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act of 2023; Worker Walkaround Representative Designation Process; H.R. 5420, Workplace Overdose Reversal Kits (WORK) to Save Lives Act; H.J.Res.147 - Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Occupational Safety and Health Administration relating to "Worker Walkaround Representative Designation Process"; S.4260 - Warehouse Worker Protection Act
Client expense: $183,083 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE
2024 · third_quarter · Health Issues
H.R.5420/S.2948 - WORK to Save Lives Act - growing co-sponsorship support for bill effort which mandates naloxone be available in Public buildings and have OSHA create guidance for private employers stocking it Issues related to NIOSH creating workplace-centered mental health programs
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
- S.2333 - Pandemic and All-Hazards Preparedness and Response Act, provisions related to health care provider workforce - S.1176 & H.R.2663 - Workplace Violence Prevention for Health Care and Social Service Workers Act - S.4928 - Beryllium Testing Fairness Act - H.R.4897 & S.2501 - Asuncion Valdivia Heat Illness and Fatality Prevention Act - H.R.5420 & S.2948 - WORK (Workplace Overdose Reversal Kits) to Save Lives Act - H.R. 766 & S.114 - Dr. Michael C. Burgess Preventive Health Savings Act - Authorization legislation to establish a program to provide federal support to graduate medical education programs in occupational and environmental medicine. - Medicare GME system reforms to accommodate support for additional medical specialty residency funding support. - Support of Congressional oversight on issues related to occupational respirable crystalline silica exposures. - Support of Congressional oversight on issues related to occupational lead exposures. - Support of Congressional oversight on issues related to on-site workplace clinic illness and injury management.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Occupational Safety & Health Administration (OSHA), SENATE
2024 · third_quarter · Budget/Appropriations
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Client expense: $500,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2024 · third_quarter · Health Issues
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Client expense: $500,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE
2024 · third_quarter · Homeland Security
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Client expense: $500,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2024 · third_quarter · Disaster Planning/Emergencies
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Client expense: $500,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2024 · second_quarter · Disaster Planning/Emergencies
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; FAA reauthorization - increasing access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948; School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946; Protecting Kids from Fentanyl Act of 2023 - H.R. 4582; Saving Lives in Schools Act of 2023 - H.R. 4240
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Homeland Security
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; FAA reauthorization - increasing access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948; School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946; Protecting Kids from Fentanyl Act of 2023 - H.R. 4582; Saving Lives in Schools Act of 2023 - H.R. 4240
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Budget/Appropriations
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; FAA reauthorization - increasing access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948; School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946; Protecting Kids from Fentanyl Act of 2023 - H.R. 4582; Saving Lives in Schools Act of 2023 - H.R. 4240
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
- S.2333 - Pandemic and All-Hazards Preparedness and Response Act, provisions related to health care provider workforce - S.1176 & H.R.2663 - Workplace Violence Prevention for Health Care and Social Service Workers Act - S.4928 - Beryllium Testing Fairness Act - H.R.4897 & S.2501 - Asuncion Valdivia Heat Illness and Fatality Prevention Act - H.R.5420 & S.2948 - WORK (Workplace Overdose Reversal Kits) to Save Lives Act - H.R. 766 & S.114 - Dr. Michael C. Burgess Preventive Health Savings Act - Authorization legislation to establish a program to provide federal support to graduate medical education programs in occupational and environmental medicine. - Medicare GME system reforms to accommodate support for additional medical specialty residency funding support. - Support of Congressional oversight on issues related to occupational respirable crystalline silica exposures. - Support of Congressional oversight on issues related to occupational lead exposures. - Support of Congressional oversight on issues related to on-site workplace clinic illness and injury management. - Advocated for the issuance of an interim OSHA standard for occupational heat stress.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Occupational Safety & Health Administration (OSHA), SENATE
2024 · second_quarter · Consumer Issues/Safety/Products
Susan Harwood Training Grants; Occupational Safety and Health Administration heat standard; Marijuana use and protections for workplace safety and health; Mental Health; Substance Abuse and Awareness; H.R.4897/S.2501 - Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act of 2023; Worker Walkaround Representative Designation Process; H.R. 5420, Workplace Overdose Reversal Kits (WORK) to Save Lives Act; H.J.Res.147 - Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Occupational Safety and Health Administration relating to "Worker Walkaround Representative Designation Process"; S.4260 - Warehouse Worker Protection Act
Client expense: $244,907 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE
2024 · second_quarter · Health Issues
H.R. 5625, the Fentanyl Awareness for Children and Teens in Schools (FACTS) Act, which would help to address the opioid crisis by making naloxone available in school settings. Support H.R. 5420 / S. 2948, the Workplace Overdose Reversal Kits (WORK) to Save Lives Act which would require opioid overdose reversal medications to be in federal buildings and create non-mandatory guidance for private employers on how to obtain these medications; both important measures to reduce opioid overdose fatalities. Support H.R. 6161, the Supporting Access to Vital and Affordable Care for Everyone (SAVE) Act, which would make access to over-the-counter naloxone more affordable by ensuring it qualifies as a deductible medical expense.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2024 · second_quarter · Homeland Security
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Budget/Appropriations
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Disaster Planning/Emergencies
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240
Client expense: Not reported · Firm income: $45,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Disaster Planning/Emergencies
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Client expense: $460,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2024 · second_quarter · Budget/Appropriations
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Client expense: $460,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2024 · second_quarter · Homeland Security
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Client expense: $460,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2024 · second_quarter · Health Issues
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.
Client expense: $460,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE
2024 · first_quarter · Homeland Security
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone FAA reauthorization - increasing access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Budget/Appropriations
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone FAA reauthorization - increasing access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Disaster Planning/Emergencies
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone FAA reauthorization - increasing access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Consumer Issues/Safety/Products
Susan Harwood Training Grants; Occupational Safety and Health Administration heat standard; Marijuana use and protections for workplace safety and health; Mental Health; Substance Abuse and Awareness; H.R.4897/S.2501 - Asuncion Valdivia Heat Illness, Injury, and Fatality Prevention Act of 2023; Worker Walkaround Representative Designation Process; H.R. 5420, Workplace Overdose Reversal Kits (WORK) to Save Lives Act
Client expense: $284,300 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE